{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T09:15:53Z","timestamp":1788340553300,"version":"build-2803163510"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to investigate whether the systemic inflammation response index (SIRI) acts as a mediator between the apolipoprotein B\/A1 ratio and atrial fibrillation, and assess the combined discriminative ability of the two indicators for identifying AF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>In this retrospective single-center analysis, a final cohort of 638 individuals was enrolled for analysis. Among them, persistent atrial fibrillation (PeAF) was diagnosed in 212 cases and paroxysmal AF (PAF) in 212. The reference group comprised 214 age-matched inpatients without AF. To investigate the associations among SIRI, the ApoB\/ApoA1, and AF risk, we used a multivariable analysis. Additionally, fully adjusted logistic regression models with restricted cubic spline (RCS) terms were employed to explore potential nonlinear relationships between SIRI, the ApoB\/ApoA1, and AF presence. Spearman analysis was used to assess their monotonic relationship. Mediation analysis was conducted with ApoB\/ApoA1 as the exposure and SIRI as the mediator, with AF as the outcome. ROC analyses were performed to evaluate the discriminative accuracy of ApoB\/ApoA1, SIRI, and their combination for AF detection. DeLong's test was used to compare the AUCs. Sensitivity, specificity, and Brier score were calculated across multiple cutoff points, with the Youden index identifying the optimal threshold. Finally, we performed a subgroup analysis stratified by the use of lipid-lowering drugs to evaluate the potential effect modification by lipid-lowering therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>\n                      The mediation analysis indicated that SIRI served as a partial statistical mediator of the inverse ApoB\/ApoA1\u2013AF relationship. The ROC analysis showed AUCs of 0.728 for ApoB\/ApoA1, 0.760 for SIRI and 0.799 for the combined model. When contrasted with ApoB\/ApoA1 alone, the ApoB\/ApoA1\u2009+\u2009SIRI combination achieved a significantly higher AUC (DeLong test,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001). Compared with SIRI alone, the integrated model also yielded a notably larger AUC (DeLong test,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.002). The ApoB\/ApoA1\u2009+\u2009SIRI model exhibited the highest AUC, along with improved specificity, the lowest Brier score, and positive discriminative value. Besides, these findings are not affected by lipid-lowering drug use. However, given the cross-sectional design, these finding reflects statistical interdependence rather than a causal sequence.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Elevated SIRI and reduced ApoB\/ApoA1 were significantly associated with higher odds of AF. The statistical mediation effect of SIRI suggests a potential interrelationship among these variables. The combined model outperformed all others in discriminative performance, offering a practical exploratory tool for patient stratification. However, these findings require independent external validation and prospective confirmation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1915694","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T09:10:08Z","timestamp":1786612208000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The inflammatory marker SIRI acts as a statistical mediator between ApoB\/ApoA1 ratio and atrial fibrillation, and combined biomarkers show higher discriminative ability for the presence of atrial fibrillation than single indicators"],"prefix":"10.3389","volume":"13","author":[{"given":"Chenyang","family":"Zheng","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Anhui Medical University Affiliated Fuyang People\u2019s Hospital, Fuyang People\u2019s Hospital","place":["Fuyang, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meixue","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Anhui Medical University Affiliated Fuyang People\u2019s Hospital, Fuyang People\u2019s Hospital","place":["Fuyang, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Ning","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Anhui Medical University Affiliated Fuyang People\u2019s Hospital, Fuyang People\u2019s Hospital","place":["Fuyang, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/eurjpc\/zwac263","article-title":"U-shaped relationship between apolipoprotein A1 levels and mortality risk in men and women","volume":"30","author":"Faaborg-Andersen","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1002\/ijc.34164","article-title":"Low apolipoprotein A1 was associated with increased risk of cancer mortality in patients following percutaneous coronary intervention: a 10-year follow-up study","volume":"151","author":"Nishiyama","year":"2022","journal-title":"Int J Cancer"},{"key":"B3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/ana.26425","article-title":"Apob and non-HDL cholesterol versus LDL cholesterol for ischemic stroke risk","volume":"92","author":"Johannesen","year":"2022","journal-title":"Ann Neurol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1001\/jamacardio.2021.5083","article-title":"Association of apolipoprotein B-containing lipoproteins and risk of myocardial infarction in individuals with and without atherosclerosis: distinguishing between particle concentration, type, and content","volume":"7","author":"Marston","year":"2022","journal-title":"JAMA Cardiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e936425","DOI":"10.12659\/MSM.936425","article-title":"Case-control study to investigate the association between serum apolipoprotein B\/A1 ratio and atrial fibrillation by sex in 920 patients from China","volume":"28","author":"Zhong","year":"2022","journal-title":"Med Sci Monit"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1161\/CIRCRESAHA.114.303211","article-title":"The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms","volume":"114","author":"Andrade","year":"2014","journal-title":"Circ Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1161\/CIRCRESAHA.117.311081","article-title":"Translational challenges in atrial fibrillation","volume":"122","author":"Heijman","year":"2018","journal-title":"Circ Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1161\/hc4901.101760","article-title":"C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation","volume":"104","author":"Chung","year":"2001","journal-title":"Circulation"},{"key":"B9","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1253\/circj.CJ-15-0138","article-title":"Role of inflammation in atrial fibrillation pathophysiology and management","volume":"79","author":"Harada","year":"2015","journal-title":"Circ J"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the european association for cardio-thoracic surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1161\/01.cir.92.9.2419","article-title":"Reduction in cardiovascular events during pravastatin therapy. Pooled analysis of clinical events of the pravastatin atherosclerosis intervention program","volume":"92","author":"Byington","year":"1995","journal-title":"Circulation"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland coronary prevention study group","volume":"333","author":"Shepherd","year":"1995","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1161\/01.cir.96.7.2455","article-title":"Incidence of and risk factors for atrial fibrillation in older adults","volume":"96","author":"Psaty","year":"1997","journal-title":"Circulation"},{"key":"B14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1159\/000006942","article-title":"Cholesterol paradox in patients with paroxysmal atrial fibrillation","volume":"92","author":"Annoura","year":"1999","journal-title":"Cardiology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.21037\/apm-20-451","article-title":"A nonlinear relationship between low-density-lipoprotein cholesterol levels and atrial fibrillation among patients with hypertension in China","volume":"9","author":"Huang","year":"2020","journal-title":"Ann Palliat Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/clc.22864","article-title":"Lipid profile and incidence of atrial fibrillation: a prospective cohort study in China","volume":"41","author":"Li","year":"2018","journal-title":"Clin Cardiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S1674-8301(11)60036-5","article-title":"ApoB\/apoA1 is an effective predictor of coronary heart disease risk in overweight and obesity","volume":"25","author":"Lu","year":"2011","journal-title":"J Biomed Res."},{"key":"B18","first-page":"74","article-title":"Apob\/ApoA1 ratio and subclinical atherosclerosis","volume":"27","author":"Panayiotou","year":"2008","journal-title":"Int Angiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s00392-018-1381-5","article-title":"Apolipoproteins A1, B, and ApoB\/apoA1 ratio are associated with first ST-segment elevation myocardial infarction but not with recurrent events during long-term follow-up","volume":"108","author":"Bodde","year":"2019","journal-title":"Clin Res Cardiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/j.1365-2265.2010.03953.x","article-title":"Apolipoprotein B\/A1 ratio is associated with free androgen index and visceral adiposity and may be an indicator of metabolic syndrome in male children and adolescents","volume":"74","author":"Lee","year":"2011","journal-title":"Clin Endocrinol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1177\/0003319717748771","article-title":"Association between serum LDL-C and ApoB and SYNTAX score in patients with stable coronary artery disease","volume":"69","author":"Lin","year":"2018","journal-title":"Angiology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"9597","DOI":"10.1038\/s41598-022-13773-2","article-title":"Association between serum apolipoprotein B and atrial fibrillation: a case-control study","volume":"12","author":"Zhong","year":"2022","journal-title":"Sci Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1007\/s00125-006-0259-7","article-title":"Apolipoprotein B: a predictor of inflammatory status in postmenopausal overweight and obese women","volume":"49","author":"Faraj","year":"2006","journal-title":"Diabetologia"},{"key":"B24","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.atherosclerosis.2010.04.012","article-title":"Reduction in serum ApoB is associated with reduced inflammation and insulin resistance in post-menopausal women: a MONET study","volume":"211","author":"Faraj","year":"2010","journal-title":"Atherosclerosis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3390\/biom9120785","article-title":"LCAT, ApoD, and ApoA1 expression and review of cholesterol deposition in the Cornea","volume":"9","author":"Flores","year":"2019","journal-title":"Biomolecules"},{"key":"B26","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/emmm.201200224","article-title":"Molecular mechanisms of vascular effects of high-density lipoprotein: alterations in cardiovascular disease","volume":"4","author":"Besler","year":"2012","journal-title":"EMBO Mol Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/labinvest.2016.56","article-title":"Apoa1 and ApoA1-specific self-antibodies in cardiovascular disease","volume":"96","author":"Chistiakov","year":"2016","journal-title":"Lab Invest"},{"key":"B28","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1161\/01.RES.0000146094.59640.13","article-title":"Antiinflammatory properties of HDL","volume":"95","author":"Barter","year":"2004","journal-title":"Circ Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"6625","DOI":"10.1038\/s41598-019-42959-4","article-title":"Decomposition and oxidation of methionine and tryptophan following irradiation with a nonequilibrium plasma jet and applications for killing cancer cells","volume":"9","author":"Uchida","year":"2019","journal-title":"Sci Rep"},{"key":"B30","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s11095-013-1199-9","article-title":"Oxidation of therapeutic proteins and peptides: structural and biological consequences","volume":"31","author":"Torosantucci","year":"2014","journal-title":"Pharm Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nm.3459","article-title":"An abundant dysfunctional apolipoprotein A1 in human atheroma","volume":"20","author":"Huang","year":"2014","journal-title":"Nat Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/s12872-023-03283-y","article-title":"Association between serum apolipoprotein A1 and atrial fibrillation in the Chinese population: a case-control study","volume":"23","author":"Zhong","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"B33","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s40001-022-00733-9","article-title":"Systemic immune inflammation index and system inflammation response index are potential biomarkers of atrial fibrillation among the patients presenting with ischemic stroke","volume":"27","author":"Lin","year":"2022","journal-title":"Eur J Med Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1666658","DOI":"10.3389\/fmed.2025.1666658","article-title":"Association between systemic inflammation response index and atrial fibrillation in chronic obstructive pulmonary disease: a multicenter cross-sectional study","volume":"12","author":"Xu","year":"2025","journal-title":"Front Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e20240783","DOI":"10.1590\/1806-9282.20240783","article-title":"The role of the systemic inflammatory response index in predicting postoperative atrial fibrillation","volume":"71","author":"Erkan","year":"2025","journal-title":"Rev Assoc Med Bras"},{"key":"B36","doi-asserted-by":"publisher","first-page":"494","DOI":"10.25122\/jml-2025-0085","article-title":"Inflammatory biomarkers for predicting postoperative atrial fibrillation in cardiac surgery","volume":"18","author":"Staicu","year":"2025","journal-title":"J Med Life"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1724217","DOI":"10.3389\/fcvm.2025.1724217","article-title":"Association and impact of inflammatory markers and cardiac structure on atrial fibrillation risk: a study integrating NHANES with real-world data","volume":"12","author":"Wang","year":"2026","journal-title":"Front Cardiovasc Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/j.jacc.2012.04.063","article-title":"Inflammation in atrial fibrillation","volume":"60","author":"Guo","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1161\/CIRCULATIONAHA.113.005837","article-title":"Oxidative stress and atrial fibrillation: finding a missing piece to the puzzle","volume":"128","author":"Yang","year":"2013","journal-title":"Circulation"},{"key":"B40","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/joa3.12077","article-title":"Inflammation and atrial fibrillation: a comprehensive review","volume":"34","author":"Korantzopoulos","year":"2018","journal-title":"J Arrhythm"}],"updated-by":[{"DOI":"10.3389\/fcvm.2026.1968329","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000}}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1915694\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:29:56Z","timestamp":1788337796000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1915694\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":40,"alternative-id":["10.3389\/fcvm.2026.1915694"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1915694","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"article-number":"1915694"}}